| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Comments |
A Polymorphisms of the Tumor Necrosis Factor
Gene Promotor Are Not Associated with Features of the Insulin Resistance Syndrome or Altered Birth Weight in Danish Caucasians1
Steno Diabetes Center and Hagedorn Research Institute (S.K.R., S.A.U., J.N.J., T.H., O.P.), DK-2820, Gentofte, Denmark; and Center of Preventive Medicine (K.B.-J.), Glostrup University Hospital, DK-2600, Glostrup, Denmark
Address correspondence and requests for reprints to: Søren K. Rasmussen, M.Sc., Steno Diabetes Center, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.
Abstract
Recently, two G
A polymorphisms at positions -308 and -238, in the
promoter of the tumor necrosis factor
(TNF-
) gene, have been
identified. These variants have, in different ethnic groups, been
linked to estimates of insulin resistance and obesity. The objective of
the present study was to investigate whether these genetic variants of
TNF-
were associated with features of the insulin resistance
syndrome or alterations in birth weight in two Danish study populations
comprising 380 unrelated young healthy subjects and 249
glucose-tolerant relatives of type 2 diabetic patients, respectively.
All study participants underwent an iv glucose tolerance test with the
addition of tolbutamide after 20 min. In addition, a number of
biochemical and anthropometric measures were performed on each subject.
The subjects were genotyped for the polymorphisms by applying PCR
restriction fragment length polymorphism. Neither of the variants was
related to altered insulin sensitivity index or other features of the
insulin resistance syndrome (body mass index, waist to hip ratio, fat
mass, fasting serum lipids or fasting serum insulin or C-peptide).
Birth weight and the ponderal index were also not associated with the
polymorphisms. In conclusion, although the study was carried out on
sufficiently large study samples, the study does not support a major
role of the -308 or -238 substitutions of the TNF-
gene in the
pathogenesis of insulin resistance or altered birth weight among Danish
Caucasian subjects.
This article has been cited by other articles:
![]() |
Z. Z. Zhao, D. R. Nyholt, L. Le, S. Thomas, C. Engwerda, L. Randall, S. A. Treloar, and G. W. Montgomery Genetic variation in tumour necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample Hum. Reprod., September 1, 2007; 22(9): 2389 - 2397. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Asghar, S. Yoshida, S. Kennedy, K. Negoro, W. Zhuo, S. Hamana, S. Motoyama, S. Nakago, D. Barlow, and T. Maruo The tumor necrosis factor-{alpha} promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population Hum. Reprod., November 1, 2004; 19(11): 2509 - 2514. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Fernandez-Real and W. Ricart Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome Endocr. Rev., June 1, 2003; 24(3): 278 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jaquet, D. A. Tregouet, T. Godefroy, V. Nicaud, D. Chevenne, L. Tiret, P. Czernichow, and C. Levy-Marchal Combined Effects of Genetic and Environmental Factors on Insulin Resistance Associated With Reduced Fetal Growth Diabetes, December 1, 2002; 51(12): 3473 - 3478. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Straczkowski, I. Kowalska, A. Stepien, S. Dzienis-Straczkowska, M. Szelachowska, and I. Kinalska Increased Plasma-Soluble Tumor Necrosis Factor-{alpha} Receptor 2 Level in Lean Nondiabetic Offspring of Type 2 Diabetic Subjects Diabetes Care, October 1, 2002; 25(10): 1824 - 1828. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Escobar-Morreale, R. M. Calvo, J. Sancho, and J. L. San Millan TNF-{alpha} and Hyperandrogenism: A Clinical, Biochemical, and Molecular Genetic Study J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3761 - 3767. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rosmond, M. Chagnon, C. Bouchard, and P. Björntorp G-308A Polymorphism of the Tumor Necrosis Factor {{alpha}} Gene Promoter and Salivary Cortisol Secretion J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2178 - 2180. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |